Euda Health Holdings Limited - Ordinary Shares EUDA 深 沪
已收盘 10-31 16:00:00 美东时间
2.10
+0.050
+2.44%
华盛通- 最 高2.1336
- 今 开2.05
- 成交量 2.81万股
- 最 低 2.02
- 昨 收 2.05
- 总市值 7802.84万
- 52周最高 6.30
- 市盈率 静 --
- 换手率 0.08%
- 52周最低 1.03
- 委 比 -74.31%
- 总股本 3715.64万
- 历史最高 10.50
- 量 比 0.28
- 振 幅 5.54%
- 历史最低 0.4334
- 每 手 1
- 风险率 0.93%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多EUDA Subsidiary CK Health Plus Expands into India in Strategic Partnership with SafeRock India
EUDA Health Holdings Limited, a Singapore-based non-invasive healthcare provider, announced that its subsidiary, CK Health Plus, will expand into the Indian market through a strategic partnership with SafeRock India. The partnership aims to leverage CK Health Plus' Bioenergy Capsule Therapies and supplements with SafeRock India's operational presence and local network to build a sustainable wellness ecosystem. This collaboration targets India's g...
10-23 13:00
EUDA Health Holdings' CK Health Plus Receives A Direct Selling License From Malaysian Ministry Of Domestic Trade And Cost Of Living
EUDA Health Holdings Limited (NASDAQ: EUDA) ("EUDA" or the "Company"), a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced that its wholly-ownedEUDA Health Holdings Limited (NASDAQ:EUDA) ("EUDA" or the
10-20 21:02
EUDA Subsidiary CK Health Plus Secures Malaysia Direct Selling License, Strengthening Its Longevity Business Across Asia
EUDA Health Holdings Limited, a Singapore-based healthcare provider, announced that its subsidiary CK Health Plus has been granted a Direct Selling License by the Malaysian Ministry of Domestic Trade. This milestone allows CK Health Plus to legally operate direct selling and multi-level marketing nationwide, enabling the expansion of Bioenergy Capsule Centers and EUDA Helixé supplement distribution. The company aims to redefine preventive healthc...
10-20 13:00
EUDA Health Holdings Adjusts Convertible Note Agreement with Investor
The latest announcement is out from EUDA Health Holdings ( ($EUDA) ). On August...
09-22 19:28
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Bone Biologics (NASDAQ:BBLG) shares increased by 30.4% to $2.7 during ...
09-04 20:08
EUDA Strategically Expands into T-Cell Immunotherapy – Strengthening Its Stem Cell Therapy Portfolio
EUDA Health Holdings has secured distribution rights for T-cell immunotherapies developed by Shenzhen Inno in Malaysia, marking its second major move into advanced cell therapy this year. The therapy, priced at USD 8,000 per treatment, aims to enhance accessibility to cutting-edge immunotherapy while addressing high costs in the region. The partnership with Shenzhen Inno and Keylock reflects EUDA's commitment to expanding its healthcare portfolio...
09-04 12:00
EUDA Signs Letter of Intent to Potentially Acquire Chemokine Pte Ltd
EUDA Health Holdings Limited (NASDAQ: EUDA), a leading non-invasive healthcare provider in Asia, has signed a Letter of Intent (LOI) to potentially acquire Chemokine Pte Ltd, a Singapore-based biotech company specializing in molecular supplements and gene modulating formulations. Chemokine has granted EUDA exclusive worldwide distribution rights for its next-generation immune health supplement, Euda Helixé. founded by molecular medicine researche...
08-28 12:00
EUDA launches gene-modulating supplement; sending shares up premarket
Shares of EUDA Health Holdings (NASDAQ:EUDA) rose 10% in the premarket trade on Tuesday after the company announced that it has secured exclusive global distribution rights for a next-generation immun...
08-26 21:43
EUDA Health Holdings Announces That Its Subsidiary, EUDA Health Pte. Ltd Has Secured Exclusive Global Distribution Rights For A Next-Generation Immune Health Supplement From Chemokine Pte. Ltd
EUDA Health Holdings Limited (NASDAQ:EUDA) ("EUDA" or the "Company"), a leading Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced that its wholly-owned
08-26 20:02
EUDA Expands Wellness Product Portfolio With A Next-Generation Immune Health Supplement
EUDA Health Holdings (NASDAQ: EUDA), a Singapore-based non-invasive healthcare provider, has secured exclusive global distribution rights for a next-generation immune health supplement, Euda Helixé, developed by Chemokine Pte. Ltd. The product, leveraging advanced epigenetic technology, aims to enhance metabolism, boost vitality, and support longevity by activating beneficial genes and silencing harmful ones. Initially targeting Singapore, Malays...
08-26 12:00
